Mission Bio rallies $30 mln Series B
South San Francisco-based Mission Bio Inc, a provider of single-cell DNA analysis and precision genomics solutions, has secured $30 million in Series B funding. The investors were Agilent Technologies, Cota Capital, LAM Capital and Mayfield.
13 December 2018•4 mins read
